Kyoto, Japan

Yuta Kudo

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Omron Healthcare, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuta Kudo. Retrieved from https://idiyas.com/inventor/yuta-kudo-c8opaedt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuta Kudo and an Electronic Sphygmomanometer for Detecting Possible Atrial Fibrillation.

Introduction

Yuta Kudo is an inventor associated with Kyoto, Japan, and Omron Healthcare, Inc. His patent work includes technology for measuring blood pressure and assessing whether a person’s pulse patterns may indicate atrial fibrillation.

Latest Patents

Kudo is associated with 1 patent: “Electronic sphygmomanometer and method for determining atrial fibrillation in an electronic sphygmomanometer.” The invention measures blood pressure from pulse-wave signals collected during cuff depressurization. It calculates pulse-wave intervals for individual measurement occasions, aggregates data from three or more occasions, and compares irregular intervals with an allowable range around the average. This approach helps determine whether there may be a possibility of atrial fibrillation.

Career Highlights

The available information connects Kudo’s patent activity with Omron Healthcare, Inc. The invention combines blood-pressure measurement with analysis of pulse-wave intervals, supporting the identification of potentially irregular heart rhythms during measurement.

Collaborations

Yukiya Sawanoi and Terumasa Naito are identified as Kudo’s coworkers. The available details do not specify their roles in the patent or the invention.

Conclusion

Yuta Kudo’s patent describes an electronic sphygmomanometer that uses repeated pulse-wave measurements to assess possible atrial fibrillation, linking blood-pressure monitoring with rhythm analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…